Published in Immunotherapy Weekly, September 8th, 2004
Known as the Yankton Clinical Research Alliance, the 2-year project includes Avera Sacred Heart Hospital, Yankton Medical Clinic and the University of South Dakota School of Medicine.
Metabolic syndrome affects 1 in every 4 Americans, and can lead to heart disease, stroke, diabetes and even death, said study director Dr. Michael Hein of Yankton Medical Clinic and the USD medical school.
"The interest and concern in this area have grown substantially during...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.